The Unblinding: Has Lilly Solved the Alzheimer’s Puzzle? — An Epilogue
The search continues.
Adam Wren
Read More
The Unblinding: Has Lilly Solved The Alzheimer’s Puzzle?
Eli Lilly and Company has spent three decades and $3 billion in an Ahab-like quest to develop the world’s first effective drug to treat Alzheimer’s disease.
Adam Wren
Read More
Top Doctors Q&A: Malaz A. Boustani
“Personally, I don’t take any of these medications or recommend them to my family members.”
Amy Lynch
Read More
Life after Zyprexa: the Future of Eli Lilly and Company
“We want high quality of life as long as possible, don’t we?” says Lilly executive Jan Lundberg. “Many of our current diseases are chronic, and they accumulate with age, so there are major demands coming from the aging population.”